Loading...
Rising Costs And Regulation Will Erode Medicare Advantage Profitability
AnalystLowTarget's Fair Value
US$2.50
2.4% overvalued intrinsic discount23 Aug
US$2.56
1Y
-37.9%7D
-2.3%1Y
-37.9%7D
-2.3%You can edit this narrative until Aug 23 10:21 PM. Then, changes will post as Updates.